Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 208111
Company: PADAGIS ISRAEL
Company: PADAGIS ISRAEL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE | 0.137MG/SPRAY;0.05MG/SPRAY | SPRAY, METERED;NASAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/18/2021 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
SPRAY, METERED;NASAL; 0.137MG/SPRAY;0.05MG/SPRAY
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE | 0.137MG/SPRAY;0.05MG/SPRAY | SPRAY, METERED;NASAL | Prescription | No | AB | 207712 | APOTEX |
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE | 0.137MG/SPRAY;0.05MG/SPRAY | SPRAY, METERED;NASAL | Prescription | No | AB | 208111 | PADAGIS ISRAEL |
DYMISTA | AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE | 0.137MG/SPRAY;0.05MG/SPRAY | SPRAY, METERED;NASAL | Prescription | Yes | AB | 202236 | MYLAN SPECIALITY LP |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English